REMS
Contraindicated in:
Use Cautiously in:
CV: hypotension
Derm: photosensitivity, rash, SKIN CANCER (NONMELANOMA), STEVENS-JOHNSON SYNDROME (SJS)
EENT: acute angle-closure glaucoma (hydrochlorothiazide), acute myopia (hydrochlorothiazide)
Endo: hyperglycemia
F and E: hypokalemia, dehydration, hypercalcemia, hypochloremic alkalosis, hypomagnesemia, hyponatremia, hypophosphatemia, hypovolemia
GI: anorexia, cramping, hepatitis, nausea, pancreatitis, vomiting
Hemat: thrombocytopenia
MS: muscle cramps
Drug-drug:
Chlorothiazide
(Generic available)Chlorthalidone
(Generic available)Hydrochlorothiazide
(Generic available)
Chlorothiazide
Chlorthalidone
Hydrochlorothiazide
chlorothiazide: Diuril,
chlorthalidone (thiazide-like): Hemiclor, Thalitone,
hydroCHLOROthiazide: Inzirqo, Microzide
Therapeutic Classification: antihypertensives, diuretics
Pharmacologic Classification: thiazide diuretics
Absorption: All are rapidly absorbed after oral administration.
Distribution: Well distributed to tissues.
Half-Life: Chlorothiazide: 12 hr; chlorthalidone: 3550 hr; hydrochlorothiazide: 615 hr.
( diuretic effect)
| ROUTE | ONSET | PEAK | DURATION | |||
|---|---|---|---|---|---|---|
| Chlorothiazide | 15 min | 30 min | 2 hr | |||
| Chlorthalidone | 2 hr | 2 hr | 4872 hr | |||
| Hydrochlorothiazide‡ | 2 hr | 36 hr | 612 hr |
‡Onset of antihypertensive effect is 34 days and does not become maximal for 714 days of dosing.